TOP
Financial Results - For the First Half of FYE March 2018 -
Contents
1. Overview for the First Half
2. Outlook for the Second Half and Full-year
Summary - FYE March 2018
Use of Cash Flows
Food: Grow in Sales of Domestic Core Products and International Business, and Reduce Cost
Food: Steadily Grow Sales of
Probiotics
and Yogurt
Food: Continue Sales Growth of Chocolate -
Health and Premium
Food:
Bean to Bar
- Meiji's strength
Food: Change the Packaging for Drinking Milk
Food: Business in China - Realize Solid Growth with Profit Increase
Food: Establish Integrated R&D System and Create Unique Values
Pharma: Steady Sales Growth and Further Low-Cost Operation
Pharma: Steady Sales Growth Focusing Mainstay Brand-name Drugs and Generic Drugs in Japan (1)
Pharma: Steady Sales Growth Focusing Mainstay Brand-name Drugs and Generic Drugs in Japan (2)
Pharma: Started Selling Generic Drugs Manufactured in Medreich on Schedule in Japan
Pharma: Establish Quality Control System Comply with Japanese GMP
Appendix
Back cover